Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter double-blind placebo-controlled study of cholestyramine for chronic watery diarrhea due to bile acid malabsorption
2009-011149-14Phase 4Active
- Sponsor
- Hospital Universitari MútuaTerrassa - Gastroenterology Department
- Start
- Feb 2010
- Modality
- Small Molecules, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Chronic diarrhea and bile acid diarrhea (BAD) comparing cholestyramine with placebo (2 arms). Primary endpoint: Clinical remission rate at 8 weeks. Started Feb 2010; status: active.
02
Drugs
cholestyramine
03
Conditions
Chronic diarrheabile acid diarrhea (BAD)
Beyond the preview
Go deeper on 2009-011149-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011149-14.